AATB Names C5 Biomedical CEO Tim Maye Among 50 Honorees Marking the Association's 50th Anniversary

Markets PR Newswire By PR Newswire 06 Oct 2026 15:54 1 min read
AATB Names C5 Biomedical CEO Tim Maye Among 50 Honorees Marking the Association's 50th Anniversary

Maye, CTBS, has spent nearly three decades in the field, including six years chairing AATB's Standards Committee BOCA RATON, Fla., Oct. 6, 2026 /PRNewswire/ -- C5 Biomedical LLC, an FDA-registered, AATB-accredited manufacturer of amniotic membrane allografts, today announced that its...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.